Literature DB >> 8320241

Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis.

B Heym1, Y Zhang, S Poulet, D Young, S T Cole.   

Abstract

The isoniazid susceptibility of Mycobacterium tuberculosis is mediated by the product of the katG gene which encodes the heme-containing enzyme catalase-peroxidase. In this study, the chromosomal location of katG has been established and its nucleotide sequence has been determined so that the primary structure of catalase-peroxidase could be predicted. The M. tuberculosis enzyme is an 80,000-dalton protein containing several motifs characteristic of peroxidases and shows strong similarity to other bacterial catalase-peroxidases. Expression of the katG gene in M. tuberculosis, M. smegmatis, and Escherichia coli was demonstrated by Western blotting (immunoblotting). Homologous genes were detected in other mycobacteria, even those which are naturally insensitive to isoniazid.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8320241      PMCID: PMC204858          DOI: 10.1128/jb.175.13.4255-4259.1993

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  32 in total

1.  Nucleotide sequence of katG of Salmonella typhimurium LT2 and characterization of its product, hydroperoxidase I.

Authors:  P C Loewen; G V Stauffer
Journal:  Mol Gen Genet       Date:  1990-10

2.  The new tuberculosis.

Authors:  D E Snider; W L Roper
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

3.  Bacterial catalase-peroxidases are gene duplicated members of the plant peroxidase superfamily.

Authors:  K G Welinder
Journal:  Biochim Biophys Acta       Date:  1991-11-15

4.  Identification of an insertion sequence, IS1081, in Mycobacterium bovis.

Authors:  D M Collins; D M Stephens
Journal:  FEMS Microbiol Lett       Date:  1991-09-15       Impact factor: 2.742

5.  Alterations in the superoxide dismutase gene of an isoniazid-resistant strain of Mycobacterium tuberculosis.

Authors:  Y Zhang; M J Garcia; R Lathigra; B Allen; C Moreno; J D van Embden; D Young
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

6.  Towards the integration of foreign DNA into the chromosome of Mycobacterium leprae.

Authors:  K Eiglmeier; N Honoré; S T Cole
Journal:  Res Microbiol       Date:  1991 Jul-Aug       Impact factor: 3.992

7.  Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis.

Authors:  S B Snapper; R E Melton; S Mustafa; T Kieser; W R Jacobs
Journal:  Mol Microbiol       Date:  1990-11       Impact factor: 3.501

8.  Characterization of a Mycobacterium tuberculosis insertion sequence, IS6110, and its application in diagnosis.

Authors:  D Thierry; A Brisson-Noël; V Vincent-Lévy-Frébault; S Nguyen; J L Guesdon; B Gicquel
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

9.  Characterization of a major polymorphic tandem repeat in Mycobacterium tuberculosis and its potential use in the epidemiology of Mycobacterium kansasii and Mycobacterium gordonae.

Authors:  P W Hermans; D van Soolingen; J D van Embden
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

10.  Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis.

Authors:  Y Zhang; R Lathigra; T Garbe; D Catty; D Young
Journal:  Mol Microbiol       Date:  1991-02       Impact factor: 3.501

View more
  70 in total

1.  A cooperative oxygen-binding hemoglobin from Mycobacterium tuberculosis.

Authors:  M Couture; S R Yeh; B A Wittenberg; J B Wittenberg; Y Ouellet; D L Rousseau; M Guertin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Nucleotide sequence of the Mycobacterium leprae katG region.

Authors:  N Nakata; M Matsuoka; Y Kashiwabara; N Okada; C Sasakawa
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

3.  Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania.

Authors:  Daiva Bakonyte; Aurelija Baranauskaite; Jurate Cicenaite; Anaida Sosnovskaja; Petras Stakenas
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  Exploring the structure and function of the mycobacterial KatG protein using trans-dominant mutants.

Authors:  Joseph A DeVito; Sheldon Morris
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

5.  Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis.

Authors:  B Saint-Joanis; H Souchon; M Wilming; K Johnsson; P M Alzari; S T Cole
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

6.  A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria.

Authors:  Makoto Niki; Mamiko Niki; Yoshitaka Tateishi; Yuriko Ozeki; Teruo Kirikae; Astrid Lewin; Yusuke Inoue; Makoto Matsumoto; John L Dahl; Hisashi Ogura; Kazuo Kobayashi; Sohkichi Matsumoto
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

7.  Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug.

Authors:  Tali H Reingewertz; Tom Meyer; Fiona McIntosh; Jaryd Sullivan; Michal Meir; Yung-Fu Chang; Marcel A Behr; Daniel Barkan
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

8.  Response of Mycobacterium tuberculosis to reactive oxygen and nitrogen intermediates.

Authors:  T R Garbe; N S Hibler; V Deretic
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

9.  Cloning, characterization and phenotypic expression in Escherichia coli of catF, which encodes the catalytic subunit of catalase isozyme CatF of Pseudomonas syringae.

Authors:  M G Klotz; Y C Kim; J Katsuwon; A J Anderson
Journal:  Appl Microbiol Biotechnol       Date:  1995 Aug-Sep       Impact factor: 4.813

10.  Elucidating the structural basis of diphenyl ether derivatives as highly potent enoyl-ACP reductase inhibitors through molecular dynamics simulations and 3D-QSAR study.

Authors:  Pharit Kamsri; Auradee Punkvang; Patchareenart Saparpakorn; Supa Hannongbua; Stephan Irle; Pornpan Pungpo
Journal:  J Mol Model       Date:  2014-06-17       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.